Pasireotide Extended-Release Injection and Valproate sodium Intravenous
Determining the interaction of Pasireotide Extended-Release Injection and Valproate sodium Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Pasireotide
Generic Name: valproic acid
Brand name: Depakene, Depacon, Stavzor, Valproate Sodium
Synonyms: Valproate sodium (Intravenous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Pasireotide Extended-Release Injection-Valproic acid
- Pasireotide Extended-Release Injection-Valproic Acid and Derivatives
- Pasireotide Extended-Release Injection-Valproic Acid Capsules
- Pasireotide Extended-Release Injection-Valproic Acid Liquid
- Pasireotide Extended-Release Injection-Valproic Acid Oral Solution
- Pasireotide Extended-Release Injection-Valproic Acid Syrup
- Valproate sodium Intravenous-Pasireotide Injection
- Valproate sodium Intravenous-Pasireotide Subcutaneous
- Valproate sodium Intravenous-Patanase
- Valproate sodium Intravenous-Patiromer
- Valproate sodium Intravenous-Patiromer Sorbitex Calcium
- Valproate sodium Intravenous-Pavacot